{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:47:11Z","timestamp":1781844431863,"version":"3.54.5"},"reference-count":46,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R44CA291336"],"award-info":[{"award-number":["R44CA291336"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Teal Health, Inc."}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Over 20 million people in the U.S. are behind on cervical cancer screenings (CCS). Sexual minority populations are 50% less likely to engage in routine screening, putting them at higher risk for cervical dysplasia and cancer due to undetected precancer and delayed diagnosis. Their barriers to speculum exams include access to care, sexual trauma, and provider bias. At-home HPV self-collection (SC) offers a clinically accurate, preferred alternative screening method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess clinical agreement, usability, and screening experiences and preferences for an FDA-authorized at-home vaginal SC device among participants who identify as lesbian, gay, bisexual, pansexual, queer, or other non-heterosexual identities (LGBQ+).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SELF-CERV was a prospective, multi-site method-comparison study conducted across 16 U.S. sites. Participants completed SC in a simulated at-home setting and underwent clinician collection with a speculum and cervical brush; paired specimens were tested for primary HPV using the Roche cobas. Surveys assessed barriers to screening, prior screening experiences, usability, and preferences. 609 participants were enrolled; 599 had paired samples, including 74 LGBQ+ participants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with heterosexual participants, LGBQ+ participants more frequently delayed or avoided screening, had lower preventive care engagement, and described worse prior speculum-based screening experiences, including higher pain, discomfort, and aversion. Clinical agreement between self- and clinician-collected specimens was comparable, with no unanticipated safety concerns. The SC device was rated as easy to use and acceptable across groups; LGBQ+ participants reported greater comfort and empowerment and a stronger preference for at-home self-collection. Qualitative comments emphasized privacy and reduced distress, including trauma- and dysphoria-related concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>At-home SC is a clinically valid, usable, and strongly preferred CCS option, particularly among LGBQ+ populations who experience disproportionate barriers to speculum-based CCS. Broader adoption of FDA-authorized at-home SC paired with telehealth will enable future impact assessment to reduce persistent disparities in CCS for LGBQ+ populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748261448263","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:16:22Z","timestamp":1778091382000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Addressing Cervical Cancer Screening Disparities: At-Home Self-Collection Among LGBQ+ Populations"],"prefix":"10.1177","volume":"33","author":[{"given":"Colleen","family":"McNicholas","sequence":"first","affiliation":[{"name":"Planned Parenthood Great Northwest"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Memmel","sequence":"additional","affiliation":[{"name":"Planned Parenthood Northern California, Obstetrics and Gynecology, San Francisco, CA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Planned Parenthood of Southern New England, Clinical Research, Hartford, CT, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-5071","authenticated-orcid":false,"given":"Youri","family":"Hwang","sequence":"additional","affiliation":[{"name":"Planned Parenthood League of Massachusetts, Clinical Research, Boston, MA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaShonda","family":"Crane","sequence":"additional","affiliation":[{"name":"Planned Parenthood Gulf Coast, Inc, Clinical Research, Houston, TX, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Orso","sequence":"additional","affiliation":[{"name":"Alabama Clinical Therapeutics\/Birmingham OBGYN, Obstetrics and Gynecology, Birmingham, AL, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Harshberger","sequence":"additional","affiliation":[{"name":"Planned Parenthood of Arizona, Obstetrics and Gynecology, Phoenix, AZ, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Lamar","family":"Parker","sequence":"additional","affiliation":[{"name":"Unified Women\u2019s Clinical Research, Obstetrics and Gynecology, Raleigh, NC, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Collins","sequence":"additional","affiliation":[{"name":"Unified Women\u2019s Clinical Research, Obstetrics and Gynecology, Raleigh, NC, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3005-3758","authenticated-orcid":false,"given":"Christine","family":"Conageski","sequence":"additional","affiliation":[{"name":"University of Colorado, Obstetrics and Gynecology, Aurora, CO, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangini","family":"Sheth","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Obstetrics and Gynecology, Hartford, CT, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-7310","authenticated-orcid":false,"given":"Lindsay","family":"Kuroki","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine in St. Louis, Obstetrics and Gynecology, St. Louis, MO, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7546-7727","authenticated-orcid":false,"given":"Jenell","family":"Coleman","sequence":"additional","affiliation":[{"name":"Johns Hopkins University, Obstetrics and Gynecology, Baltimore, MD, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8807-6434","authenticated-orcid":false,"given":"Elizabeth","family":"Sutton","sequence":"additional","affiliation":[{"name":"Woman\u2019s Hospital, Clinical Research, Baton Rouge, LA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Jennings","sequence":"additional","affiliation":[{"name":"University of Wisconsin-Madison, Obstetrics and Gynecology, Madison, WI, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-9399","authenticated-orcid":false,"given":"Emeline","family":"Aviki","sequence":"additional","affiliation":[{"name":"NYU Langone Health, Gynecologic Oncology, Mineola, NY, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-8018","authenticated-orcid":false,"given":"Megan","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Teal Health, Inc., Research, San Francisco, CA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Hibler","sequence":"additional","affiliation":[{"name":"Independent Statistician, Statistician, Bradenton, FL, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9303-6081","authenticated-orcid":false,"given":"Alexandra","family":"Ripkin","sequence":"additional","affiliation":[{"name":"Teal Health, Inc., Research, San Francisco, CA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-685X","authenticated-orcid":false,"given":"Meghna","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Teal Health, Inc., Research, San Francisco, CA, US"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"e_1_3_7_2_2","volume-title":"Cancer Facts & Figures 2025","author":"American Cancer Society","year":"2025","unstructured":"American Cancer Society. Cancer Facts & Figures 2025; 2025. Published online."},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.08.006"},{"key":"e_1_3_7_4_2","volume-title":"Increase proportion of females who get screened for cervical cancer (C-09): data methodology","author":"Office of Disease Prevention and Health Promotion","year":"2030","unstructured":"Office of Disease Prevention and Health Promotion. Increase proportion of females who get screened for cervical cancer (C-09): data methodology. Healthy People; 2030. Published online."},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/03630242.2025.2550649"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34213"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2025.101838"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-023-01771-2"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35355"},{"key":"e_1_3_7_10_2","unstructured":"P.T.S.D. National Center for PTSD. Trauma discrimination and PTSD among LGBTQ+ people. https:\/\/www.ptsd.va.gov\/professional\/treat\/specific\/trauma_discrimination_lgbtq.asp"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.168971"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-023-01420-0"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/traumacare3040029"},{"key":"e_1_3_7_14_2","first-page":"275","article-title":"Broken down by bias: healthcare biases experienced by BIPOC and LGBTQ+ patients","volume":"2021","author":"Casanova-Perez R","year":"2022","unstructured":"Casanova-Perez R, Apodaca C, Bascom E, et al. Broken down by bias: healthcare biases experienced by BIPOC and LGBTQ+ patients. AMIA Annu Symp Proc. 2022;2021:275-284.","journal-title":"AMIA Annu Symp Proc"},{"issue":"1","key":"e_1_3_7_15_2","first-page":"e30","article-title":"Cancer screening rates among transgender adults: cross-sectional analysis of primary care data","volume":"65","author":"Kiran T","year":"2019","unstructured":"Kiran T, Davie S, Singh D, et al. Cancer screening rates among transgender adults: cross-sectional analysis of primary care data. Can Fam Physician. 2019;65(1):e30-e37.","journal-title":"Can Fam Physician"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190172"},{"key":"e_1_3_7_17_2","volume-title":"Draft recommendation: cervical cancer: screening. U.S. Preventive Services Task Force","author":"U.S. Preventive Services Task Force","year":"2024","unstructured":"U.S. Preventive Services Task Force. Draft recommendation: cervical cancer: screening. U.S. Preventive Services Task Force. Publ Dec.; 2024. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/draft-recommendation\/cervical-cancer-screening-adults-adolescents"},{"key":"e_1_3_7_18_2","article-title":"FDA approves Teal Health\u2019s Teal WandTM\u2014the first and only at-home self-collection device for cervical cancer screening","author":"Teal Health","year":"2025","unstructured":"Teal Health. FDA approves Teal Health\u2019s Teal WandTM\u2014the first and only at-home self-collection device for cervical cancer screening. PR Newswire May. 2025. https:\/\/www.prnewswire.com\/news-releases\/fda-approves-teal-healths-teal-wandthe-first-and-only-at-home-self-collection-device-for-cervical-cancer-screening-introducing-a-comfortable-alternative-to-in-person-screening-302451189.html","journal-title":"PR Newswire May"},{"key":"e_1_3_7_19_2","article-title":"cobas\u00ae HPV test: delivering confidence with 3-in-1 HPV test results","author":"Roche Diagnostics","unstructured":"Roche Diagnostics. cobas\u00ae HPV test: delivering confidence with 3-in-1 HPV test results. Roche Diagn. https:\/\/diagnostics.roche.com\/se\/sv\/products\/params\/cobas-hpv.html","journal-title":"Roche Diagn"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70041"},{"key":"e_1_3_7_21_2","volume-title":"Cervical cancer: screening. U.S. Preventive Services Task Force","author":"U.S. Preventive Services Task Force","year":"2018","unstructured":"U.S. Preventive Services Task Force. Cervical cancer: screening. U.S. Preventive Services Task Force. Publ; 2018. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/cervical-cancer-screening"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.11081"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2016-052609"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11554-6"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/09691413241260019"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003743"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-00921-x"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00076-2"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106358"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/17455057251362581"},{"key":"e_1_3_7_31_2","article-title":"Cervical cancer is preventable","author":"Centers for Disease Control and Prevention","year":"2020","unstructured":"Centers for Disease Control and Prevention. Cervical cancer is preventable. Vital Signs Updat March. 2020. https:\/\/www.cdc.gov\/vitalsigns\/cervical-cancer\/index.html","journal-title":"Vital Signs Updat March"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","unstructured":"Crane L Jennings A Fitzpatrick MB et al. Experiences and preferences reported with an at-home self-collection device compared with in-clinic speculum-based cervical cancer screening in the United States. Womens Health Rep (New Rochelle). 19(1):564-575. doi:10.1089\/whr.2025.0017.","DOI":"10.1089\/whr.2025.0017"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_7_34_2","volume-title":"Applying human factors and usability engineering to medical devices: guidance for industry and Food and Drug Administration staff","author":"Food and Drug Administration","year":"2016","unstructured":"Food and Drug Administration. Applying human factors and usability engineering to medical devices: guidance for industry and Food and Drug Administration staff. Issued Febr; 2016. https:\/\/www.fda.gov\/media\/80481\/download"},{"key":"e_1_3_7_35_2","unstructured":"United States Census Bureau. QuickFacts. https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045223"},{"key":"e_1_3_7_36_2","unstructured":"Gallup. What percentage of Americans are LGBTQ+? Updated August 6. Published online 2025. https:\/\/news.gallup.com\/poll\/332522\/percentage-americans-lgbt.aspx"},{"key":"e_1_3_7_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33967"},{"key":"e_1_3_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jasc.2022.06.003"},{"key":"e_1_3_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2023.107478"},{"key":"e_1_3_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2016.11.003"},{"key":"e_1_3_7_41_2","unstructured":"Low awareness of HPV vaccine availability and cancer link persists nationwide. Am J Manag Care Publ. 2025. https:\/\/www.ajmc.com\/view\/low-awareness-of-hpv-vaccine-availability-and-cancer-link-persists-nationwide"},{"key":"e_1_3_7_42_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1783952"},{"key":"e_1_3_7_43_2","volume-title":"Division of Cancer Epidemiology and GeneticsNational Cancer Institute","author":"Stephens ES","year":"2023","unstructured":"Stephens ES, Shing JZ. Disparities in HPV and HPV vaccine awareness by education and race\/ethnicity. In: Division of Cancer Epidemiology and GeneticsNational Cancer Institute. Publ Novemb; 2023. https:\/\/dceg.cancer.gov\/news-events\/news\/2023\/education-race-hpv-awareness"},{"key":"e_1_3_7_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000885"},{"key":"e_1_3_7_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.26456"},{"key":"e_1_3_7_46_2","doi-asserted-by":"publisher","DOI":"10.5888\/pcd20.230056"},{"key":"e_1_3_7_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/20552076261421347"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748261448263","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748261448263","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748261448263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T13:49:03Z","timestamp":1778334543000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748261448263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["10.1177\/10732748261448263"],"URL":"https:\/\/doi.org\/10.1177\/10732748261448263","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/10732748261448263\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748261448263\/v1\/review3","asserted-by":"object"}]},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"article-number":"10732748261448263"}}